Table 2. Biochemical characteristics of patients.
| Biochemical characteristics | All | Patients |
P | |
| Low < 8.4 mg/L | High ≥ 8.4 mg/L | |||
| Glucose, mmol/L | 7.9 (3.1–42.3) | 7.5 (3.6–42.3) | 7.9 (3.1–41.6) | 0.633 |
| HbA1c, % | 7.9 ± 2.4 | 7.9 ± 2.3 | 8.0 ± 2.6 | 0.754 |
| Urae, mmol/L | 5.7 (2.5–30.5) | 5.4 (2.5–14.0) | 6.3 (2.9–30.5) | 0.003* |
| Creatinin, µmol/L | 93.7 ± 28.9 | 90.9 ± 25.2 | 96.4 ± 30.0 | 0.134 |
| Uric Acid, µmol/L | 309.0 (82.0–817.0) | 305.0 (199.0–633.0) | 318.0 (82.0–817.0) | 0.911 |
| TC, mmol/L | 4.4 ± 1.4 | 4.4 ± 1.4 | 4.3 ± 1.4 | 0.424 |
| TG, mmol/L | 1.4 (0.5–12.1) | 1.4 (0.5–6.1) | 1.4 (0.5–12.1) | 0.642 |
| HDL-C, mmol/L | 0.9 (0.3–2.9) | 0.9 (0.3–2.9) | 0.9 (0.3–2.0) | 0.305 |
| LDL-C, mmol/L | 2.6 (0.0–6.7) | 2.5 (0.0–6.7) | 2.6 (0.1–5.0) | 0.876 |
| Lp(a), mg/dL | 11.0 (0.2–225.8) | 10.7 (0.2–225.8) | 11.8 (1.5–101.0) | 0.172 |
| ApoA1, mg/dL | 99.1 (0.0–189.0) | 100.5 (0.0–189.0) | 97.3 (22.5–187.0) | 0.056 |
| ApoB, mg/dL | 75.2 ± 28.7 | 69.8 (1.0–166.0) | 69.1 (11.1–152.0) | 0.624 |
| ApoB/ApoA1 | 0.8 ± 0.5 | 0.7 (0.1–5.1) | 0.7 (0.2–3.1) | 0.287 |
| Hcy, µmol/L | 18.8 (3.7–50.0) | 19.2 (7.7–50.0) | 17.5 (3.7–50.0) | 0.566 |
| HGB, g/dL | 13.7 ± 8.8 | 14.3 ± 11.0 | 12.7 ± 1.9 | 0.204 |
| WBC, 103/µL | 9.4 ± 3.2 | 8.7 ± 2.7 | 10.3 ± 3.6 | < 0.001 |
| SAA, mg/L | 6.7 (0.71–1020.0) | 4.6 (0.7–338.0) | 18.3 (1.6–1020.0) | < 0.001 |
| IL-6, pg/mL | 9.0 (1.5–3640.0) | 6.0 (1.5–1957.0) | 19.8 (4.3–3640.0) | < 0.001 |
| HsCRP, mg/L | 5.9 (0.2–1020.0) | 3.1 (0.2–8.4) | 20.0 (8.5–1020.0) | < 0.001 |
Data are expressed as the mean ± SD or median (minmum value – maximum value). ApoA-1: apolipoprotein A-1; ApoB: apolipoprotein B; HbA1c: glycated hemoglobin A1c; Hcy: homocysteine; HDL-C: high density lipoprotein cholesterol; HGB: hemoglobin; Hs-CRP: high sensitivity C-reactive protein; IL-6: interleukin 6; LDL-C: low density lipoprotein cholesterol; Lp(a): lipoprotein(a); TC: total cholesterol; TG: triglyceride; SAA: serum amyloid protein; WBC: white blood cells.